Autonomic function testing in the COVID-19 pandemic: an American Autonomic Society position statement.
Juan J FigueroaWilliam P CheshireVictoria E ClaydonLucy Norcliffe-KaufmannAmanda PeltierWolfgang SingerHoward SnapperSteven VerninoSatish R Rajnull nullPublished in: Clinical autonomic research : official journal of the Clinical Autonomic Research Society (2020)
COVID-19 is a global pandemic that is wreaking havoc with the health and economy of much of human civilization. In this document from the American Autonomic Society, we identify the potential risks of exposure to patients, physicians, and allied healthcare staff. We provide guidance for conducting autonomic function testing safely in this environment.
Keyphrases
- heart rate variability
- healthcare
- heart rate
- coronavirus disease
- sars cov
- end stage renal disease
- human health
- endothelial cells
- primary care
- ejection fraction
- chronic kidney disease
- newly diagnosed
- public health
- mental health
- peritoneal dialysis
- blood pressure
- risk assessment
- patient reported outcomes
- pluripotent stem cells